Tenoxicam is a Medicine belongs to Non Sterodial Anti- Inflammatory Drugs group whose information about Brand can be referenced from   Book : Martindale    Page : 134   Edition : 37  

  ►   Brandname : Tobitil, Mobiflex
  ►  Strength : Injection with .  Tablet with .  Suppository with

Reference of this Medicine for its Strength can be taken from   Book : Martindale    Page : 134   Edition : 37  
A Route of administration in pharmacology and toxicology is the path by which a drug, fluid, poison, or other substance is taken into the body. Routes of administration are generally classified by the location at which the substance is applied. Common examples include oral and intravenous administration.

  ►  Route of administration : Oral, IM, IV, rectal
Reference :-   Book : Martindale    Page : 134   Edition : 37  

Dosing of Medicine differ in Adult & Pediatrics ↓

Adult Dose

S.No Ailment   Route   Dose Min   Dose Max   Unit   Dosage Form   Frequency   Additional Info
1 Symptomatic management of musculoskeletal and joint disorders such as osteoarthritis and rheumatoid arthritis, and also in the short-term management of soft-tissue injury Oral 20 mg Tablet Dose: given as a single oral daily dose. In acute musculoskeletal disorders treatment for up to 7 days is usually sufficient but in severe cases it may be given for up to a maximum of 14 days. Doses similar to those given orally have been given by intramuscular or intravenous injection for initial treatment for 1 or 2 days.

Ref :-  Book : Martindale    Page : 134   Edition : 37  

Pediatric Dose

S.No Ailment   Age Min   Age Max   Weight ( Kg ) Route   Dose Min   Dose Max   Unit   Dosage Form   Frequency  Additional Info  

Ref :- Book :    Page :    Edition :   
►  Side Effect : Nausea, Diarrhoea, Peptic Ulceration, Severe gastrointestinal bleeding, Headache, Vertigo, Dizziness, Nervousness, Tinnitus, Depression, Drowsiness, Insomnia, Hypersensitivity reactions, Fever, Angioedema, Bronchospasm, Rashes, Visual disturbances, Anaemias, Thrombocytopenia, Neutropenia, Eosinophilia, Agranulocytosis, Photosensitivity, Induction or exacerbation of colitis
Ref :-   Book : Martindale    Page : 100,133   Edition : 37.  

►  Drug Interaction : Drug interaction of Tenoxicam is with , Cardiac Glycosides, Angiotensin conveting enzyme inhibitors , , Diuretic Agents , Potassium -Sparing Diuretics , Beta Blockers , sulfonylurea antidiabetic , Corticosteroids, selective serotonin reuptake inhibitors, Alcohol, ,  Azapropazone, Phenylbutazone, Methotrexate, Tacrolimus , Phenytoin , Venlafaxine , Clopidogrel , Ticlopidine , Iloprost , Erlotinib, Sibutramine, Pentoxifylline , Ritonavir, Mifepristone
Ref :-   Book : Martindale    Page : 103,133   Edition : 37.  

  ►    Mechanism of Drug Drug Interaction :  Interactions involving NSAIDs include enhancement of the effects of oral anticoagulants (especially by azapropazone and phenylbutazone) and increased plasma concentrations of lithium, methotrexate, and cardiac glycosides. The risk of nephrotoxicity may be increased if given with ACE inhibitors, ciclosporin, tacrolimus, or diuretics. There may also be an increased risk of hyperkalaemia with ACE inhibitors and some diuretics, including potassiumsparing diuretics. The antihypertensive effects of some antihypertensives including ACE inhibitors, beta blockers, and diuretics may be reduced. NSAIDs may increase the effects of phenytoin and sulfonylurea antidiabetics. The risk of gastrointestinal bleeding and ulceration associated with NSAIDs is increased when used with corticosteroids, the SSRIs, the SNRI venlafaxine, the antiplatelets clopidogrel and ticlopidine, iloprost, erlotinib, sibutramine, or, possibly, alcohol, bisphosphonates, or pentoxifylline. Ritonavir may increase the plasma concentrations of NSAIDs. Licensed product information for mifepristone advises of a theoretical risk that prostaglandin synthetase inhibition by NSAIDs or aspirin may alter the efficacy of mifepristone. Ref: Martindale
Ref :-   Book : Martindale    Page : 103,133   Edition : 37.  

►  Contraindication : Active peptic ulceration, Moderate to severe heart failure, Ischaemic heart disease, Peripheral arterial disease, Cerebrovascular disease, Hypertension, Left ventricular failure, Oedema, History of hypersensitivity reactions, History of cardiac failure, and in patients with risk factors for developing heart disease, It should also be used with caution in patients with asthma or allergic disorders
Ref :-   Book : Martindale    Page : 102,133   Edition : 37.  
  ►  Mechanism of Action :   Selective inhibitor of cyclo oxygenase-2 (COX-2).
Ref :-   Book : Martindale    Page : 103   Edition : 37.  

Pathway of DIETARY Product

​   ► Act.Comp / Nutrient / Food / Herb as follows :- NA

DIETARY Substance Interactions

​   ► This Medicine interact with :- NA

ContraIndication DIETARY Substance

​   ► This Medicine contraindicate with :- NA

►   Route of Elimination :   Hepatic (Metabolism), Renal
Ref :-   Book : Martindale    Page : 133   Edition : 37.  

►    Plasma Half-life :   Min value :-   NA    Max value :-   NA

►    Peak Plasma Concentration :   Min value :-   NA    Max value :-   NA